Carlo DeAngelis, PharmD, Sunnybrook Health Sciences Center, Toronto, Canada, takes us through the use of medicinal cannabis in Canada, including the legislation, logistics and perceptions of this treatment option for pain and other side effects in patients with cancer. He highlights the need for more research on this agent. This interview took place at the International Society of Oncology Pharmacy Practitioners (ISOPP) Symposium 2019, hosted by the British Oncology Pharmacy Association (BOPA), held in London, UK.
Medicinal cannabis in cancer patients – is there a benefit?
your paid advertisement here
